Tags

3D printing 3M 3SBio 21st Century Cures Act 23andMe 340B 2016 Presidential election 2020 Presidential election AACR Aastrom Aastrom Biosciences Abbott Abbott Laboratories Abbott Labs AbbVie Abilify Abiomed Ablynx Abraxane ABT-450 abuse-resistant painkillers Acadia Acadia Pharmaceuticals ACC accelerated approvals Acceleron Access Pharmaceuticals Accuray AcelRx Achaogen Achillion AC Immune acne Acorda Acorda Therapeutics acquisitions Actavis Actelion Actemra Acthar activists Actos Acura Pharmaceuticals acute lymphoblastic leukemia acute myeloid leukemia ADA Adamis Pharmaceuticals Adaptimmune Adasuve Adcetris ADC Therapeutics Addyi ADHD adolescents Adolor aducanumab Aduhelm Advair AdvaMed Advaxis Adventrx adverse events advisory panel advisory panels Aegerion Aerie Pharma aesthetics Aeterna Zentaris Aethlon Medical Aetna Affordable Care Act Affymax Affymetrix Afinitor Afrezza Africa age-related macular degeneration Agenus Agios Agios Pharmaceuticals agreement AHA AIDS Aimmune Aimovig Ajovy Akorn Albert Bourla Alcon Aldeyra Therapeutics Alere Alex Azar Alex Gorsky Alexion Alexion Pharmaceuticals Alexza Align Technology Alimera Alimta alirocumab Alkermes Allergan allergies Allogene Allos Almirall Alnylam Alphabet ALS Alvotech Alzheimer's disease Amag Pharmaceuticals Amarin Amazon American Medical Systems AmerisourceBergen Amgen Amicus Amicus Therapeutics Amitiza AML Amneal Amphastar Ampion Ampio Pharmaceuticals Ampligen AMPYRA AMR101 Amylin Amylyx Amylyx Pharmaceuticals Amyris Amyvid Anacetrapib Anacor Anadys analysts AnaptysBio Andrew Witty Androgel Androxal anemia Angeion AngioDynamics Anika animal health ankylosing spondylitis Anoro Ellipta Antares Antares Pharma Anthem Anthera anthrax anti-aging anti-clotting anti-PD-1 immunotherapy anti-PD-L1 antibiotic resistance antibiotics antibodies antibody-drug conjugate anticoagulants antidepressants antifungals Antigenics antihypertensives antipsychotics antisense antitrust antivirals anxiety Apellis Pharmaceuticals Apixaban Apotex AP Pharma Apple Apple Watch approvals Apricus Biosciences Aranesp Arcus Biosciences Ardea Ardelyx Arena Arena Pharmaceuticals Argenx Ariad Pharma Ariad Pharmaceuticals Aricept Arqule Array Biopharma Arrowhead Pharmaceuticals arthritis ArthroCare ArtiCure artificial intelligence artificial pancreas Arzerra ASCO ASCO 2016 ASCO 2017 ASCO 2018 ASCO 2019 ASCO 2020 ASCO 2021 ASCO 2022 ASCO 2023 ASH 2022 Asia Aspen Pharmacare Assembly Biosciences Astellas Astex asthma AstraZeneca Athersys atopic dermatitis atrial fibrillation ATTR Aubagio Aurinia Pharmaceuticals Aurobindo Australia autism autoimmune disease Auxilium Avanafil Avandia Avanir Avastin avelumab Aveo Oncology Aveo Pharmaceutical Aveo Pharmaceuticals AveXis AVI BioPharma award Axovant AXS-05 Axsome Therapeutics AZD9291 BACE inhibitors bacteriophage BAN2401 bankruptcy bapineuzumab BARDA baricitinib Barr Laboratories Basilea Bausch & Lomb Bausch Health Bavarian Nordic Bavencio bavituximab Baxalta Baxter Baxter International Bayer bb2121 Beam Therapeutics Becton Dickinson BeiGene Bellicum beloranib Belviq bempedoic acid benign prostatic hyperplasia Benlysta Bernie Sanders beta thalassemia Bexsero Bextra BG-12 Bicycle Therapeutics Big Data Big Pharma Biktarvy Bill Ackman Bill Gates BIO biobucks Biocon Biocryst Biodel BioDelivery Sciences Biogen Biogen Idec BiogenIdec Biohaven BioLase biologics Biomarin biomarkers Biomet BioMimetic Therapeutics BioNTech BioSante biosimilars biotech biotech hubs biotech stocks BioTime Biotronik Biovail Bioverativ bipolar disorder birth control birth control pill birth defects bispecific antibodies black box bladder cancer blockchain blood blood cancer blood clots blood glucose monitoring bloodthinners blood thinners Bluebird Bio Blueprint Medicines Boceprevir Boehringer Ingelheim bonds boosters Boston Boston Scientific Botox Bovie Medical brain brain cancer BrainStorm Cell Therapeutics branding Brazil breakthrough status breakthrough therapies breakthrough therapy breast breast cancer breast implants Brent Saunders Breo Ellipta Brexit bribery BridgeBio Brilinta Bristol-Myers Squibb Bristol Myers Squibb brodalumab BSD Medical buyouts Bydureon Byetta C. difficile Cabometyx cabozantinib Cadence Pharmaceuticals cafepharma California Canada cancer cancer immunotherapy cancer vaccines cannabis Cantel Medical CAR-T Cara Therapeutics Cardiac Cardica Cardinal Health cardiology Cardiome Cardiovascular cardiovascular disease Cardiovascular Systems CareFusion Carfilzomib Caribou Biosciences Carl Icahn Cassava Sciences Catalent catheter catheters CDC CDER CDMO CDMOs Cel-Sci Celebrex celebrity endorsements Celgene celiac disease Cellceutix Celldex Celldex Therapeutics Cellectis Cell Therapeutics cell therapy Celltrion Celsion CE Mark Cempra CEO Cephalon Cerevel Therapeutics Cerezyme Cerus Cervarix cervical cancer CETP inhibitors CFO Chantix Charles River Laboratories Chelsea Therapeutics ChemoCentryx chemotherapy chemotherapy-induced nausea and vomiting chicago chikungunya virus Chimerix China China Medical Technologies CHMP cholesterol Chris Viehbacher chronic cough chronic kidney disease chronic lymphocytic leukemia chronic myeloid leukemia chronic pain Chugai Cialis Cigna Cinryze Cipla Class Action Lawsuit Clinical Data clinical depression clinical hold clinical trial clinical trial data clinical trial diversity clinical trials CLL Clostridium Difficile Clovis Oncology CML CMOs CMS CMV CNS Coherus Biosciences Cologuard colon cancer colorectal cancer companies compassionate use guidelines competition Complete Genomics complete response letter CompuGen Conceptus Concerta Concert Pharmaceuticals congress Conmed consumer health consumers continuous glucose monitoring contraceptives contract Contrave Cook Medical Copaxone COPD Corcept Therapeutics Cordis CoreValve Cornerstone Therapeutics coronavirus coronaviruses Cosentyx Cougar Biotechnology COVID-19 COVID-19 variants Covidien CR Bard Crestor CRISPR CRISPR Therapeutics Crohn's Disease Crohn’s disease CROs Crucell Cryolife CSL CTI BioPharma CTL019 Cubicin Cubist Cubist Pharma Cubist Pharmaceuticals Cumberland CureVac Curis Cutera CVS CVS Health CV Therapeutics cyberattacks Cyberknife Cyberonics cybersecurity Cyclacel Cymbalta Cynosure Cypress Bioscience Cyramza cystic fibrosis Cytokinetics CytomX Cytori CytRx daclatasvir Daiichi Sankyo Dainippon Sumitomo Daniel Vasella Dapagliflozin Daraprim daratumumab Darzalex data David Ricks Daxas DBV Technologies DEA debt decentralized clinical trials defibrillators Delcath Delta COVID-19 variant dementia Denali Therapeutics Dendreon dengue denosumab dental Dentsply Depakote Department of Defense Depomed depression DePuy DePuy Synthes Derma Sciences dermatology development Device device manufacturing device recalls device reps devices device tax DexCom diabetes diabetic macular edema diabetic neuropathy diabetic retinopathy diagnostics dialysis diffuse large B-cell lymphoma digital health digital marketing digital pharma digital therapeutics dimebon Diovan Discovery Labs discrimination distribution diversity dividends DMD DNA DNA sequencing DOJ Dolutegravir Donald Trump donanemab Doxil Dravet syndrome drisapersen Dr Reddy's Drug drug-device combos drug ads drug approvals drug delivery drug development drug discounts drug discovery drug importation drug launches drug manufacturing drug marketing drug names drug prices drug pricing drug rebates drug reps drug safety drug sales drug shortages drug spending drug stocks drug trials dry eye disease DTC DTC ads DTC advertising Duchenne Muscular Dystrophy dulaglutide dupilumab Dupixent Durect Corporation Dyax Dynavax earnings ebola virus Echo Therapeutics eczema Editas Medicine Edwards Lifesciences Effient EHA EHRs Eisai Elagolix Elan Elanco elderly Eli Lilly Eliquis Elizabeth Holmes Elon Musk EMA Emergency Use Authorization Emergent BioSolutions emerging markets Emgality Emma Walmsley employees Enanta Enanta Pharmaceuticals Enbrel Endo Endocyte Endo Health Solutions Endo International Endologix endometrial cancer endometriosis Enhertu Enterome EnteroMedics EntreMed Entresto environmental concerns Enzon Epidiolex epilepsy EpiPen EpiPens Epizyme Epogen Erbitux erectile dysfunction Esbriet esketamine ESMO esophageal cancer Esperion Therapeutics Essure eteplirsen Ethicon etrasimod EU Europe European evolocumab Evotec exa-cel EXACT Sciences exclusivity executive pay executives Exelixis Exondys 51 expansion EXPAREL Express Scripts Exscientia eye eye disease eye health Eylea Fabrazyme Fabry's disease Fabry disease Facebook Facet Biotech False Claims Act Fanapt Farxiga Fasenra fast track FCPA FDA federal government female sexual dysfunction FibroGen fibromyalgia fidaxomicin filgotinib financing Finch Therapeutics Five Prime Flagship Pioneering Flexion Florida Flu flu vaccine flu vaccines follicular lymphoma food allergies Forest Labs formulary Forty Seven Fosamax Foundation Medicine France fraud free speech Fresenius FTC Fujifilm funding Fusilev Galapagos Galderma Galena Biopharma Gamida Cell gantenerumab Gardasil gastric cancer Gates Foundation Gattex Gaucher disease Gazyva GE GE Healthcare gender discrimination gene editing Genentech generics gene sequencing gene therapy genetics genetic testing Genfit Genmab genomics Gentium GenVec Genzyme geographic atrophy George Scangos Germany Geron GI Dynamics Gilead Gilead Sciences Gilenya Giovanni Caforio Given Imaging glaucoma Gleevec Glenmark glioblastoma glioblastoma multiforme Global Blood Therapeutics Globus Medical GLP-1 agonist Google Gossamer Bio gout government government contracts government shutdown GPO graft vs host disease Grail grants Greatbatch Grifols GS-7977 GSK GTx Guardant Health guidance Guidant Guided Therapeutics GW Pharma H.P. Acthar Gel H1N1 hacking HAE Haemonetics Halozyme Hansen Medical Harvard Harvoni Hatch Waxman Act HCV head and neck cancer headquarters Healthcare healthcare bill Healthcare on the Hill healthcare reform hearing loss heart heart attacks heart disease heart failure heart valve heart valves HeartWare Hemispherx Hemispherx Biopharma Hemlibra hemophilia hemophilia A hemophilia B Henri Termeer hepatitis hepatitis B hepatitis C hepatocellular carcinoma Heplisav Herceptin hereditary angiodema Heron Therapeutics HHS Hikma Hill-Rom Hillary Clinton hip hip implants hip replacements hirings HIV Hodgkin's lymphoma Hologic Homozygous Familial Hypercholesterolemia Hong Kong Horizant Horizon Pharma Horizon Therapeutics Hospira Hospital hospitals hostile bid hostile takeover hot flashes HPV HRT Humalog Humana Human Genome Sciences Humira Huntington's disease hydrocodone hydroxychloroquine hypercholesterolemia hypertension Ian Read IBD IBM Ibrance ibrutinib IBS IBS-C Icagen ICD ICER Iclusig ICU Medical Idenix Idera Pharmaceuticals idiopathic pulmonary fibrosis Idorsia Ilaris Illumina Iluvien imaging Imbruvica imetelstat Imfinzi immuno-oncology ImmunoCellular ImmunoCellular Therapeutics Immunocore Immunogen immunology Immunomedics immunotherapy Impax Impax Laboratories Impax Labs Impella Implant implants Incivek inclisiran incubators Incyte Indenix India Indivior industry infant formula infectious diseases Infinity Pharmaceuticals inflammation inflammatory bowel disease Inflation Reduction Act Inflectra influenza inhaled insulin Inhibitex injectables innovation Innovent Biologics Inovio insider trading Insmed insomnia Inspire Insulet insulin insulin pumps insurance insurers Insys INSYS Therapeutics Intarcia Integra LifeSciences intellectual property Intellia Therapeutics Intercept Pharma Intercept Pharmaceuticals Intermezzo InterMune international Intra-Cellular Therapies Intrexon Intuitive Surgical Invacare investigation investment investors Invivo Therapeutics Invokana Ionis Pharmaceuticals IPF iPhone ipilimumab IPO IPOs Ipsen IQVIA Ireland Ironwood Ironwood Pharmaceuticals irritable bowel syndrome IRS Isis Pharmaceuticals IsoRay Israel Ista Italy J&J J. Michael Pearson Jakafi JAK inhibitors JAMA Janet Woodcock Janssen Janssen Biotech Janumet Januvia Japan Jardiance Javelin Jazz Pharma Jazz Pharmaceuticals Jeff Kindler JNJ job cuts jobs Joe Biden Joe Jimenez John Lechleiter Johnson & Johnson Joseph Papa Jounce Therapeutics JPMHC 2017 JPMHC 2018 JPMHC 2019 JPMHC 2020 JPMHC 2021 JPMHC 2022 JPMHC 2023 JPMHC 2024 JPMorgan Juno Therapeutics Kadcyla Kaleido Biosciences Kaleo KaloBios Kalydeco Karuna Therapeutics KarXT Karyopharm KCI Ken Frazier Kenneth Frazier Kensey Nash Kentucky Keryx Kevzara Keytruda kickbacks kidney cancer kidney disease Kinetic Concepts King Kisqali Kite Pharma knee Korea KRAS Krystexxa KTE-C19 KV Pharmaceutical Kymriah Kynamro Kyprolis Kåre Schultz LabCorp labeling La Jolla Pharmaceutical Lannett Lantus laquinimod laser lasers launch law lawsuit lawsuits layoffs LCZ696 lecanemab legal Legend Biotech legislation Lemtrada LentiGlobin Lenvima LEO Pharma Leqembi leukemia Levadex Levaquin Lexapro Lexicon Pharmaceuticals LibiGel Libtayo licensing life sciences Life Technologies Ligand Ligand Pharmaceuticals Linzess Lipitor liquid biopsy liraglutide liscensing liso-cel liver cancer liver disease lobbying logistics Long COVID Lonza lorcaserin Lou Gehrig's disease Lovenox Loxo Oncology Lpath Lucentis Lumakras Luminex Lundbeck lung cancer Lupin lupus Luxturna Lyme disease lymphoma Lymphoseek Lynparza Lyrica M&A machine learning Macrogenics macular degeneration Madrigal Pharmaceuticals Magenta Therapeutics major depressive disorder Makena Mako Surgical malaria Mallinckrodt Management MannKind mantle cell lymphoma manufacturing MAP Pharmaceuticals marijuana market marketing Martin Shkreli Maryland Masimo Massachusetts McKesson MDS MDV3100 Mead Johnson med-tech Meda Medarex Medicaid Medical Device medical devices medical device tax Medical Marijuana medical supplies Medicare Medicare Part D Medicines Company Medicis MedImmune Medivation Medivir Medtech Medtronic medullary thyroid cancer Mekinist melanoma MELA Sciences meningitis menopause Merck Merck KGaA Merck Serono Merrimack Pharmaceuticals Mesoblast mesothelioma metastatic breast cancer metastatic castration-resistant prostate cancer metastatic melanoma metastatic non-small cell lung cancer metformin Mexico microbiome Micromet Microsoft mifepristone migraines Milestone Miles White Millennium MiMedx Mindray Minnesota mipomersen Mirati Therapeutics mirikizumab Misonix MIT MK-3475 MM-398 mobile mobile apps Moderna Therapeutics molnupiravir Momenta Momenta Pharmaceuticals monitoring monkeypox monoclonal antibodies MorphoSys Mounjaro MRI MRNA mRNA-1273 MRSA MS Multaq Multikine Multiple Myeloma multiple sclerosis MultiStem muscular dystrophy myasthenia gravis myelodysplastic syndrome myelofibrosis Mylan Mylan Labs MyoKardia Myriad Myriad Genetics Namenda Namenda XR Nanosphere narcolepsy NASDAQ NASH Navidea Biopharmaceuticals NDA Nektar Nektar Therapeutics Neoprobe NeoStem neratinib Nestle Neulasta Neupogen Neuralstem Neurocrine Neurocrine Biosciences neurodegenerative disease NeurogesX neurology NeuroMetrix Neurontin Neuroscience neurostimulation NeuVax New England Journal of Medicine New Jersey NewLink Genetics New York Nexavar Nexium NGM Biopharmaceuticals NHS Niaspan NICE NicOx NIH nivolumab NKTR-214 non-Hodgkin's lymphoma non-opioid pain treatments non-small cell lung cancer North Carolina Northera Northwest Biotherapeutics Novartis Novavax Novocure Novo Nordisk NPS Pharmaceuticals Nucala Nuedexta NuPathe Nuplazid NurOwn NuVasive NUVIGIL NxStage Medical Nycomed Obagi Medical Products Obama obesity obeticholic acid OCA Ocaliva ocrelizumab Ocrevus Ocular Therapeutix Oculus Innovative Sciences off-label Ofirmev Ohio Olivier Brandicourt olumiant Olympus Olysio Omecamtiv Mecarbil Omeros Omicron COVID-19 variant OncoGenex oncologists oncology Oncolytics OncoMed OncoSec Oncothyreon Onglyza Onpattro Onyx ONYX Pharmaceuticals Opana ER Opdivo OPDP Operation Warp Speed Opexa ophthalmology Ophthotech opiods opioid addiction opioid crisis opioids OPKO Health Optimer Optimer Pharmaceuticals options OraSure Orencia Orexigen Organon Organovo Orkambi orphan drugs Orthofix orthopaedics Orthopedics Orthovita OSI Pharmaceuticals Osiris Osiris Therapeutics osteoarthritis osteoarthritis of the knee osteoporosis OTC Otezla Otsuka ovarian cancer overactive bladder overtime lawsuits Ovid Therapeutics Oxford BioMedica Oxigene oxycontin ozanimod Ozempic P&G pacemakers Pacific Biosciences Pacira Padcev PAH painkillers pain management Pain Therapeutics palbociclib pancreatic cancer pandemic Paratek Parkinson's Disease Parkinson's Disease Psychosis Par Pharmaceutical PARP inhibitors partnerships Pascal Soriot patent patent cliff Patent Infringement patents patient patient deaths patients Patisiran Paul Hudson Paxil Paxlovid pay-for-delay payers PBMs PCSK9 inhibitors PDL Biopharma PDUFA peanut allergy Pear Therapeutics pediatric pediatrics pelvic mesh peramivir Peregrine Pharmaceuticals perifosine Perjeta PerkinElmer Perrigo Perrigo Company personalized medicine Pfizer pharma advertising Pharma CEOs pharmacies Pharmacyclics pharma industry pharma marketing Pharmasset pharma stocks PharmAthene philanthropy Philidor Rx Philips PhRMA physician access physician gifts physician payments Physician Payment Sunshine Act physicians pimavanserin Pinnacle Hip pipelines Piramal Healthcare pirfenidone pixantrone PKU Plan B contraceptive Plavix plecanatide Pluristem Pluristem Therapeutics PMA PML pneumococcal disease pneumonia PNH politics Pomalyst Pompe disease Portola Pharmaceuticals postpartum depression Pozen Pradaxa Praluent precision medicine pregnancy Premier Prempro PrEP prescription data Pressure BioSciences Prevnar Prevnar 13 price fixing priority review priority review vouchers Pristiq Probuphine Prochymal Procrit Proctor & Gamble product recalls profits Progenics Progenics Pharmaceuticals Prolia Prolor Prosensa prostate cancer Protalix BioTherapeutics protein degradation Prothena Provenge Provention Bio Provigil pSivida psoriasis psoriatic arthritis PTC Therapeutics PTSD Public Citizen Public Health Puerto Rico pulmonary arterial hypertension Puma Biotechnology Purdue Purdue Pharma Qiagen QLT Qnexa Qsymia Quad Questcor Questcor Pharmaceuticals Quest Diagnostics R&D radiation Radient Pharmaceuticals Radiology radiopharmaceuticals radiotherapy Radius Health Ranbaxy Raptor Pharmaceuticals rare disease Rare Diseases Ratiopharm real world data real world evidence Reata Pharmaceuticals rebates recall recalls Receptos Reckitt Benckiser regenerative medicine Regeneron Regenxbio regorafenib regulatory Regulus reimbursement Relistor Relypsa remdesivir Remicade Remoxy renal cell carcinoma renal denervation reorganization Repatha Repligen Repros Therapeutics reputation research ResMed Respiratory Restasis restless legs syndrome restructuring Retrophin Revance Therapeutics revenues Revlimid Rexahn rheumatoid arthritis Rhythm Pharmaceuticals Riata Richard Gonzalez ridaforolimus Rigel Rigel Pharmaceuticals right-to-try laws Rinvoq risdiplam Risperdal Rituxan RNA RNAi Robert Califf robotics robotic surgery Roche rociletinib Rockwell Medical Roivant romosozumab Rova-T roxadustat Royalty Pharma RSV Rubraca Russia ruxolitinib RWE RXi Pharmaceuticals Sackler family safety SAGE Therapeutics salaries sales sales reps Salix samples Samsung Bioepis Samsung BioLogics Sandoz San Francisco Sangamo BioSciences Sangamo Therapeutics Sanofi Sanofi Genzyme Sanofi Pasteur Santarus Santhera Sanuwave Sapien sarcoma Sarepta Sarepta Therapeutics Savient Saxenda Schering Plough schizophrenia SciClone Scott Gottlieb Seagen Seattle Genetics SEC securities fraud semaglutide Senate Sepracor Sequenom Seres Therapeutics Seroquel Servier settlements severe asthma Severin Schwan SGLT2 inhibitor shareholders share repurchase shingles Shingrix Shionogi Shire short bowel syndrome sickle cell disease side effects Siemens SIGA technologies Silenor Simcere Simponi Singapore Singulair Sinovac Sirona Dental skin cancer Skyrizi sleep apnea SMA small cell lung cancer small molecule drugs Smith & Nephew smoking cessation Sobi social media sofosbuvir software solanezumab Solid Biosciences solid tumors Soliris Solithromycin Solta Medical Solvay Somaxon SonoSite Sorrento Therapeutics South Africa South Korea Sovaldi SPAC SPACs Spain Spark Therapeutics Spectranetics Spectrum Pharmaceuticals Spinal spinal muscular atrophy Spine spinoff spinoffs Spinraza Sprout Pharmaceuticals Sprycel SRP-9001 St. Jude Medical Stada start-ups startups statins Stelara StemCells stem cells Stendra stent stents Stephane Bancel Stephen Hahn Stereotaxis Steris Stimuvax stock stock buyback stock offering stocks stomach cancer Strides Arcolab stroke Stryker Suboxone Subsys Sucampo suicide Sunesis Sunovion Sun Pharma superbugs Supergen Supernus Pharmaceuticals supply supply chain Supreme Court Surfaxin surgery surgical sustainability Sutent suvorexant Sweden swine flu Switzerland Symbicort Symmetry Medical Synergetics Synergy Pharmaceuticals Syneron Syneron Medical Synlogic Synta Synta Pharmaceuticals Synthes T-DM1 tafamidis Tafinlar Tagrisso Takeda talazoparib Talecris Taltz Tamiflu Tandem Diabetes tanezumab Tarceva tardive dyskinesia Targacept Taro Tasigna TAVR tax taxes tax inversions tax reform Tecentriq Tecfidera tech technology Tekmira Pharmaceuticals Telaprevir Teleflex Medical telehealth telemedicine television ads Tesaro testosterone Tetraphase Pharmaceuticals Teva Teva Pharmaceutical Teva Pharmaceuticals Texas TG Therapeutics TH-302 The Cooper Companies The Medicines Company Theragenics Theranos therapy Theravance ThermoDox Thermo Fisher Thermogenesis Thoratec Threshold Pharmaceuticals thyroid cancer thyroid eye disease tiragolumab tirzepatide Titan Titan Pharmaceuticals tivozanib tofacitinib TomoTherapy Topamax Toujeo trade secrets training Transcept Translate Bio transparency Tranzyme treatment Tredaptive tremelimumab Tremfya Tresiba trials Trimeris triple negative breast cancer Trius Therapeutics Trodelvy TrueBeam Trulicity Truvada tuberculosis Turing Pharmaceuticals Turning Point Therapeutics twitter Tykerb Tylenol type 1 diabetes type 2 diabetes Tysabri UCB Pharma UCB Pharmaceuticals UK Ukraine ulcerative colitis Ultomiris Ultragenyx ultrasound Unilife uniQure United States United Therapeutics University of Oxford Upadacitinib upgrades Upjohn urothelial cancer US US Congress user fees uterine fibroids UTIs vaccine vaccines Valeant Pharmaceuticals Valneva Vanda Vanda Pharmaceuticals Varian Varian Medical Vascepa vascular Vascular Solutions Vas Narasimhan Vaxart Vectibix Vectura Vedanta Biosciences Veklury Velcade Venclexta ventilators venture capital Verastem Verily Versant Ventures Vertex Vertex Pharmaceuticals Verve Therapeutics Verzenio veterinary medicine Viagra Viaskin Peanut Viatris Vical Victoza Victrelis Viekira Pak ViiV ViiV Healthcare Viking Systems Viking Therapeutics vintafolide Vioxx Vir Biotechnology Viread ViroPharma Vivek Ramaswamy Vivus Volcano Corporation Vorapaxar Voyager Therapeutics Vyndaqel Vytorin Vyvanse Walgreens Walgreens Boots Alliance Walmart Warfarin Warner Chilcott warnings Warren Buffett Watson Watson Pharmaceuticals Wave Life Sciences wearables Wegovy weight loss wet age-related macular degeneration whistleblower lawsuits whistleblowers White House WHO William Weldon women Women's Health women executives wound care Wright Medical Wuhan Coronavirus WuXi PharmaTech Wyeth Xalkori Xarelto Xeljanz Xencor XenoPort Xgeva Xiaflex Xience Xifaxan Xiidra Xolair Xoma Xtandi Xyrem Yaz Yervoy Yescarta YM BioSciences Zafgen Zalicus Zaltrap Zantac Zarxio Zealand Pharma Zejula Zelboraf Zeltiq Zepatier Zepbound Zerenex Zetia Zevalin Zika virus Zimmer Zimmer Biomet Ziopharm Zoetis Zogenix Zohydro Zohydro ER Zolgensma ZOLL Medical Zoloft Zometa Zostavax zuranolone Zymeworks ZymoGenetics Zynteglo Zyprexa Zytiga